Latest News

CEBIPHAR updates

Nitrosamines : no one-size-fits-all method. A testing strategy tailored to your product.

📃 Since 2019, the regulatory framework on nitrosamines in pharmaceutical products has kept evolving. Systematic risk evaluation, confirmatory testing, marketing authorization variations, lifecycle management : the ICH M7 guidelines have progressively expanded these requirements for manufacturers. But beyond the regulatory text, the real challenge is analytical : detecting genotoxic impurities down to 18 ng/day (CPCA […]

Read the article
Filter by category :
All categories
Pharmaceuticals and Medical Device news
TERANGA updates
CEBIPHAR updates
Filtrer par catégorie :
CEBIPHAR updates

WITH 94% OF CLIENT SATISFACTION RATE, WHY NOT WORKING WITH US?

As part of our sustainable customer experience program, a customer satisfaction survey was conducted in June 2021, aiming to build long-term relationships with our...
Read more
CEBIPHAR updates

CEBIPHAR awarded with a contract (call for tender) related to the French government’s recovery plan for so called “essential” drugs

The French government recovery plan: Several pharma companies are focused on providing solutions to meet the needs of hospitals for essential drugs The pandemic...
Read more
CEBIPHAR updates

CEBIPHAR Toulouse : Opening of a pharmaceutical establishment

CEBIPHAR gets authorization from ANSM and ANSES for the opening of a pharmaceutical establishment on Toulouse site We are pleased to announce that after...
Read more
Pharmaceuticals and Medical Device news variété médicaments Cebiphar

FDA 2020: Still a promising year for small molecules

DRUG THERAPIES   In 2020, despite the COVID situation, the FDA approved different type of drug therapies, with the aim of improving the health...
Read more
Pharmaceuticals and Medical Device news microbiological test Cebiphar

RELOCATION: The government plan and the related projects

Et quia minima amet corporis sed dicta aperiam rerum excepturi cupiditate dolor fugit totam sed eaque quibusdam atque dolores molestiae id dicta eius asperiores...
Read more